Plan Group Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.18M Buy
113,348
+13,552
+14% +$361K 0.75% 43
2025
Q4
$2.48M Buy
99,796
+18,081
+22% +$456K 0.64% 44
2025
Q3
$2.08M Buy
81,715
+16,670
+26% +$411K 0.56% 61
2025
Q2
$1.58M Buy
65,045
+10,761
+20% +$251K 0.52% 65
2025
Q1
$1.38M Buy
54,284
+18,495
+52% +$484K 0.49% 56
2024
Q4
$949K Buy
35,789
+4,472
+14% +$121K 0.5% 49
2024
Q3
$906K Buy
31,317
+3,289
+12% +$95.9K 0.48% 49
2024
Q2
$784K Buy
28,028
+12,904
+85% +$355K 0.48% 47
2024
Q1
$420K Buy
15,124
+5,339
+55% +$148K 0.28% 57
2023
Q4
$282K Sell
9,785
-1,196
-11% -$36.2K 0.25% 55
2023
Q3
$364K Sell
10,981
-4,328
-28% -$153K 0.26% 43
2023
Q2
$549K Buy
+15,309
New +$596K 0.46% 34
2022
Q2
$386K Buy
+7,364
New +$375K 0.66% 34

Other funds holding PFE

Plan Group Financial's PFE Position: Q1 2026 in Review

Plan Group Financial increased its Pfizer (PFE) stake by 14% in Q1 2026, buying an estimated $361K and bringing the position to 113,348 shares worth $3.18M. The position accounts for 0.75% of the portfolio, ranked #43.

Plan Group Financial first reported a position in PFE in Q2 2022 and has held it in 13 quarters since. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Plan Group Financial held 113,348 shares of Pfizer worth $3.18M as of Q1 2026.
  • Plan Group Financial bought 13,552 Pfizer shares in Q1 2026, an estimated $361K.
  • Pfizer made up 0.75% of Plan Group Financial's portfolio in Q1 2026, its #43 holding.
  • Plan Group Financial first reported a position in Pfizer in Q2 2022 and has held it in 13 quarters since.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Plan Group Financial's 13F filing for Q1 2026, filed 13 Apr 2026.